Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Characteristics and Bleeding Behavior of Females with Mild Hemophilia A: Longitudinal Study from Picnichealth Hemophilia A Database

Angela C. Weyand, Hwai Jing Hiew, Yanrong Jiang, Athanasios Siadimas, Francis Nissen, Gillian Hanson, Emily Cibelli, Katya Moreno, Hanlu Zhang, Anjali Sharathkumar

Blood (2022) 140 (Supplement 1): 61–62.

https://doi.org/10.1182/blood-2022-157727

Published: 2022

Journal Articles

Mortality Trends Among Persons with Hemophilia in the United States, 2000-2021

Amanda B Payne, Binh Le, Meredith A Oakley, Brandi Dupervil, Marilyn J Manco-Johnson, Anjali Sharathkumar, Stacy E. Croteau, Rajiv K. Pruthi, Skye J Peltier, Norma Wolf, Roshni Kulkarni, Vanessa R Byams

Blood (2022) 140 (Supplement 1): 65–66.

https://doi.org/10.1182/blood-2022-163208

Published: 2022

Journal Articles

Characterization of Bleeding and Laboratory Phenotype of Carriers of Hemophilia and Trends of Utilization of Factor Concentrates and Hemostatic Therapies: Analysis of the National Athndataset

Neeraja Swaminathan, Brian Hu, Alison Currie, Roshni Kulkarni, Steven W. Pipe, Michael Recht, Peter A. Kouides, Anjali Sharathkumar

Blood (2022) 140 (Supplement 1): 59–60.

https://doi.org/10.1182/blood-2022-158861

Published: 2022

Journal Articles

Characteristics and Healthcare Utilization of Patients with Mild or Moderate Hemophilia A in the US - an Analysis from the Picnichealth Cohort

Anjali Sharathkumar, Yanrong Jiang, Hwai Jing Hiew, Athanasios Siadimas, Francis Nissen, Gillian Hanson, Emily Cibelli, Katya Moreno, Johnny Wharton, Angela C. Weyand

Blood (2022) 140 (Supplement 1): 2762–2763.

https://doi.org/10.1182/blood-2022-157712

Published: 2022

Journal Articles

Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment

Blood (2021) 138 (Supplement 1): 4310.

https://doi.org/10.1182/blood-2021-153346

Published: 2021

Journal Articles

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Jacqueline Halton, MD, Leonardo R. Brandao, MD, Matteo Luciani, MD, Lisa Bomgaars, MD, Elizabeth Chalmers, MD, Lesley Mitchell, MD, Ildar Nurmeev, MD, Anjali Sharathkumar, MD, Pavel Svirin, MD, Kirill Gorbatikov, MD, Igor Tartakovsky, MD, Monika Simetzberger, DI, Fenglei Huang, PhD, Zhichao Sun, PhD, Jörg Kreuzer, MD, Savion Gropper, MD, Martina Brueckmann, MD, Manuela Albisetti, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-136682

Published: 2020

Journal Articles

Epidemiology of Inhibitors in Persons with Severe Hemophilia a in the United States: Analyses of a National Database

Christopher M Sande, BSc, Amanda B Payne, MPH, PhD, Christine L Kempton, MD MSc, Marilyn J Manco-Johnson, MD, Anjali Sharathkumar, MBBS, MDMS

Blood (2018) 132 (Supplement 1): 2470.

https://doi.org/10.1182/blood-2018-99-109978

Published: 2018

Journal Articles

Characteristics of Males with Hemophilia in the United States Hemophilia Treatment Center Network (USHTCN) with New-Onset Elevated Inhibitor Titers, December 15, 2013 - December 31, 2016

Marilyn J Manco-Johnson, MD, J. Michael Soucie, PhD, Anjali Sharathkumar, MBBS, MDMS, Fiona Bethea, MPH, Christine L Kempton, Amanda B. Payne, MPH, Michael Wang, MD, Connie H Miller, PhD

Blood (2017) 130 (Supplement 1): 3408.

https://doi.org/10.1182/blood.V130.Suppl_1.3408.3408

Published: 2017

Journal Articles

Validation of the Peds Clot Clinical Decision Rule [PCDR] in Hospital-Acquired Venous Thromboembolism

Rachael Schultz, BA, Soyang Kwon, PhD, Anjali Sharathkumar, MBBS, MDMS, Rukhmi Bhat, MDMS

Blood (2017) 130 (Supplement 1): 3709.

https://doi.org/10.1182/blood.V130.Suppl_1.3709.3709

Published: 2017

Journal Articles

Prospective Validation of the Peds Clot Clinical Decision Rule [Pdcr] in Hospital-Acquired Venous Thromboembolism: An Interim Analysis

Rachael F Schultz, BA, Soyang Kwon, PhD, Anjali Sharathkumar, MD MS, Rukhmi Bhat, MD MS

Blood (2016) 128 (22): 3812.

https://doi.org/10.1182/blood.V128.22.3812.3812

Published: 2016

Journal Articles

Current Practice Patterns of Phamacological Thromboprophylaxis for Prevention of Venous Thromboembolism in Hospitalized Children: A Survey of Pediatric Hemostasis and Thrombosis Experts in North America

Sherif M Badawy, MD, Anjali Sharathkumar, MDMS

Blood (2014) 124 (21): 4274.

https://doi.org/10.1182/blood.V124.21.4274.4274

Published: 2014

Journal Articles

Trends of Venous Thromboembolism (VTE) and Risk Factors for Developing VTE in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT) in children’s Hospitals-a PHIS Database Study

Surabhi Batra, MBBS, Lawrence Salud, Patti Duda, David Bertoch, MBA, Reggie Duerst, MD, Matt Hall, PhD, Anjali Sharathkumar, MDMS

Blood (2014) 124 (21): 1474.

https://doi.org/10.1182/blood.V124.21.1474.1474

Published: 2014

Journal Articles

RISK-Prediction MODEL for DEVELOPMENT of Venous Thromboembolism In HOSPITALIZED CHILDREN

Arash Mahajerin, MD, Robert Fallon, MD, PhD, George Eckert, MAS, Mark Heiny, MD, PhD, Terry Vik, MD, Anjali Sharathkumar, MD, MS

Blood (2011) 118 (21): 2281.

https://doi.org/10.1182/blood.V118.21.2281.2281

Published: 2011

Journal Articles

Validation of Post-Thrombotic Syndrome Outcome Scale for Children with Extremity and Non-Extremity Venous Thromboembolism (VTE).

Anjali Sharathkumar, Elaine Southwood, Robert Fallon, Mark Heiny

Blood (2010) 116 (21): 3669.

https://doi.org/10.1182/blood.V116.21.3669.3669

Published: 2010

Journal Articles

Antiphospholipid Syndrome: Clinical Characteristics of Patients and Affected Family Members From Multiplex Families.

Thomas L. Ortel, MD, PhD, Fatih Cagri Sarikaya, Ahmet Alptekin, Karen E. Hansen, MD, Robert A.S. Roubey, MD, Anjali Sharathkumar, MD, Robert W. Hoffman, DO, Margaret Pericak-Vance, PhD, Jeffery Vance, MD, PhD, Susan Hahn, MS, CGC, Silke Schmidt, PhD

Blood (2009) 114 (22): 2972.

https://doi.org/10.1182/blood.V114.22.2972.2972

Published: 2009

Journal Articles

Cardiovascular Disease in Patients with Hemophilia: Single Centre Experience.

Anjali Sharathkumar, MD, Brandy Trawinski, LPN, BLS, J. Michael Soucie, PhD, Anne Greist, MD, Craig Haddix, Amy D. Shapiro, MD

Blood (2008) 112 (11): 2272.

https://doi.org/10.1182/blood.V112.11.2272.2272

Published: 2008

Journal Articles

Outcome of Children with Hyperdiploid Acute Lymphoblastic Leukemia- an Apparent Predisposition for Extramedullary Relapse and High Salvage Rate. A Single Institution Experience.

Anjali Sharathkumar, MD, Mehul Patel, Ronald Thomas, PhD, Yaddanapudi Ravindranath, MD, Jeffrey W. Taub, MD

Blood (2004) 104 (11): 1956.

https://doi.org/10.1182/blood.V104.11.1956.1956

Published: 2004

NARROW

Characteristics and Bleeding Behavior of Females with Mild Hemophilia A: Longitudinal Study from Picnichealth Hemophilia A Database

Mortality Trends Among Persons with Hemophilia in the United States, 2000-2021

Characterization of Bleeding and Laboratory Phenotype of Carriers of Hemophilia and Trends of Utilization of Factor Concentrates and Hemostatic Therapies: Analysis of the National Athndataset

Characteristics and Healthcare Utilization of Patients with Mild or Moderate Hemophilia A in the US - an Analysis from the Picnichealth Cohort

Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Epidemiology of Inhibitors in Persons with Severe Hemophilia a in the United States: Analyses of a National Database

Characteristics of Males with Hemophilia in the United States Hemophilia Treatment Center Network (USHTCN) with New-Onset Elevated Inhibitor Titers, December 15, 2013 - December 31, 2016

Validation of the Peds Clot Clinical Decision Rule [PCDR] in Hospital-Acquired Venous Thromboembolism

Prospective Validation of the Peds Clot Clinical Decision Rule [Pdcr] in Hospital-Acquired Venous Thromboembolism: An Interim Analysis

Current Practice Patterns of Phamacological Thromboprophylaxis for Prevention of Venous Thromboembolism in Hospitalized Children: A Survey of Pediatric Hemostasis and Thrombosis Experts in North America

Trends of Venous Thromboembolism (VTE) and Risk Factors for Developing VTE in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT) in children’s Hospitals-a PHIS Database Study

RISK-Prediction MODEL for DEVELOPMENT of Venous Thromboembolism In HOSPITALIZED CHILDREN

Validation of Post-Thrombotic Syndrome Outcome Scale for Children with Extremity and Non-Extremity Venous Thromboembolism (VTE).

Antiphospholipid Syndrome: Clinical Characteristics of Patients and Affected Family Members From Multiplex Families.

Cardiovascular Disease in Patients with Hemophilia: Single Centre Experience.

Outcome of Children with Hyperdiploid Acute Lymphoblastic Leukemia- an Apparent Predisposition for Extramedullary Relapse and High Salvage Rate. A Single Institution Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only